Icon Wealth Partners’s Charles River Laboratories CRL Stock Holding History

Icon Wealth Partners’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$378K	Sell	1,930 -916	-32%	-$188K	0.04%	202
2023 Q2	$598K	Sell	2,846 -389	-12%	-$77.4K	0.06%	174
2023 Q1	$653K	Buy	+3,235	New	+$733K	0.07%	170
2022 Q2	$658K	Sell	3,076 -396	-11%	-$96.8K	0.08%	175
2022 Q1	$986K	Sell	3,472 -32	-0.9%	-$9.87K	0.1%	152
2021 Q4	$1.32M	Buy	3,504 +307	+10%	+$119K	0.13%	135
2021 Q3	$1.32M	Buy	3,197 +177	+6%	+$73.5K	0.14%	144
2021 Q2	$1.12M	Buy	3,020 +327	+12%	+$109K	0.12%	147
2021 Q1	$781K	Buy	+2,693	New	+$749K	0.1%	163
2020 Q3	–	Sell	-1,390	Closed	-$242K	–	268
2020 Q2	$242K	Buy	+1,390	New	+$222K	0.06%	219
2018 Q1	–	Sell	-59	Closed	-$6K	–	360
2017 Q4	$6K	Buy	+59	New	+$6.42K	﹤0.01%	755

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Icon Wealth Partners's CRL Position: Q3 2023 in Review

Icon Wealth Partners reduced its Charles River Laboratories (CRL) stake by 32% in Q3 2023, selling an estimated $188K and leaving 1,930 shares worth $378K. The position accounts for 0.04% of the portfolio, ranked #202.

Icon Wealth Partners first reported a position in CRL in Q4 2017 and has held it in 11 quarters since. The position peaked at $1.32M in Q4 2021. 621 funds tracked by Wall St. Rank hold CRL as of Q3 2023.

Icon Wealth Partners held 1,930 shares of Charles River Laboratories worth $378K as of Q3 2023.
Icon Wealth Partners sold 916 Charles River Laboratories shares in Q3 2023, an estimated $188K.
Charles River Laboratories made up 0.04% of Icon Wealth Partners's portfolio in Q3 2023, its #202 holding.
Icon Wealth Partners first reported a position in Charles River Laboratories in Q4 2017 and has held it in 11 quarters since.
Icon Wealth Partners's Charles River Laboratories position peaked at $1.32M in Q4 2021.
621 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.